1st monthly HIV drug doesn't receive FDA approval

iStock/Bowonpat Sakaew(WASHINGTON) — The Food and Drug Administration declined the approval of Cabenuva, the first long-acting HIV drug on Saturday. “Clearly this is disappointing and not the news we hoped for,” said a spokesperson from ViiV Healthcare,
Read More